These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8485877)

  • 1. Evaluation of seven Cholestech L.D.X analyzers for total cholesterol determinations.
    Rogers EJ; Misner L; Ockene IS; Nicolosi RJ
    Clin Chem; 1993 May; 39(5):860-4. PubMed ID: 8485877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Cholestech L.D.X. desktop analyser for cholesterol, HDL-cholesterol, and triacylglycerols in heparinized venous blood.
    Cobbaert C; Boerma GJ; Lindemans J
    Eur J Clin Chem Clin Biochem; 1994 May; 32(5):391-4. PubMed ID: 8086524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of lipid profile measurements obtained from the Cholestech L.D.X analyzer.
    Bard RL; Kaminsky LA; Whaley MH; Zajakowski S
    J Cardiopulm Rehabil; 1997; 17(6):413-8. PubMed ID: 9421763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Precision and accuracy of blood lipid analyses by a portable device (Cholestech-LDX)].
    Issa JS; Strunz C; Giannini SD; Forti N; Diament J
    Arq Bras Cardiol; 1996 Jun; 66(6):339-42. PubMed ID: 9035449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inaccuracy of lipid measurements with the portable Cholestech L.D.X analyzer in patients with hypercholesterolemia.
    Stein JH; Carlsson CM; Papcke-Benson K; Einerson JA; McBride PE; Wiebe DA
    Clin Chem; 2002 Feb; 48(2):284-90. PubMed ID: 11805009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of three dry-chemistry methods for lipid profiling and risk factor classification.
    Rubin DA; McMurray RG; Harrell JS; Carlson BW; Bangdiwala S
    Int J Sport Nutr Exerc Metab; 2003 Sep; 13(3):358-68. PubMed ID: 14669935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of two compact analyzers used for lipid analysis.
    McKenney JM; Fary DF; Miller G; Proctor JD; Chinchili VM
    J Fam Pract; 1993 May; 36(5):526-33. PubMed ID: 8482937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytic and clinical performance of two compact cholesterol-testing devices.
    Volles DF; McKenney JM; Miller WG; Ruffen D; Zhang D
    Pharmacotherapy; 1998; 18(1):184-92. PubMed ID: 9469692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments.
    Dale RA; Jensen LH; Krantz MJ
    Ann Pharmacother; 2008 May; 42(5):633-9. PubMed ID: 18413684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eight compact analysis systems evaluated for measuring total cholesterol.
    Gregory LC; Duh SH; Christenson RH
    Clin Chem; 1994 Apr; 40(4):579-85. PubMed ID: 8149614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision of a dry-chemistry method of lipid screening.
    Bowden RG; Kingery PM; Long L
    Public Health; 2006 Jun; 120(6):572-6. PubMed ID: 16730036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How reliably can compact chemistry analyzers measure lipids?
    Kaufman HW; McNamara JR; Anderson KM; Wilson PW; Schaefer EJ
    JAMA; 1990 Mar; 263(9):1245-9. PubMed ID: 2304240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of current National Cholesterol Education Program guidelines for total cholesterol triglyceride, HDL-cholesterol, and LDL-cholesterol measurements.
    Caudill SP; Cooper GR; Smith SJ; Myers GL
    Clin Chem; 1998 Aug; 44(8 Pt 1):1650-8. PubMed ID: 9702951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood cholesterol concentration measured by CR3000: fingerstick versus venous sampling.
    Sblendorio V; Palmieri B; Riccioni G
    Int J Immunopathol Pharmacol; 2008; 21(3):729-33. PubMed ID: 18831942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkaline phosphatase activity: new assay for the Reflotron system. Results of the evaluation in eight clinical laboratories.
    Schumann G; Dominick HC; Hellmann D; Klauke R; Möckesch M; Stekel H; von Schenck H; Kraft M; Nagel R; Hänseler E
    Clin Chem Lab Med; 2001 Jan; 39(1):71-8. PubMed ID: 11256805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood cholesterol concentration: fingerstick plasma vs venous serum sampling.
    Greenland P; Bowley NL; Meiklejohn B; Doane KL; Sparks CE
    Clin Chem; 1990 Apr; 36(4):628-30. PubMed ID: 2323042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reflotron performance in a community screening program: results of the Massachusetts Model Systems for Blood Cholesterol Screening Project.
    Havas S; Bishop R; Koumjian L; Reisman J; Wozenski S
    Am J Prev Med; 1991; 7(6):397-405. PubMed ID: 1790049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of the Reflotron in the determination of cholesterol.
    Selmer R; Foss OP; Lund-Larsen PG
    Scand J Clin Lab Invest; 1990 May; 50(3):261-71. PubMed ID: 2353155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the Accuracy of 2 Point-of-Care Lipid Testing Devices.
    Bastianelli K; Ledin S; Chen J
    J Pharm Pract; 2017 Oct; 30(5):490-497. PubMed ID: 27313238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EDTA-plasma vs serum differences in cholesterol, high-density-lipoprotein cholesterol, and triglyceride as measured by several methods.
    Beheshti I; Wessels LM; Eckfeldt JH
    Clin Chem; 1994 Nov; 40(11 Pt 1):2088-92. PubMed ID: 7955384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.